December 21, 2016    1 minute read

Allergan To Buy Acelity

   December 21, 2016    1 minute read

Allergan To Buy Acelity

Pharmaceutical giant Allergan announced that it would buy medicine unit LifeCell owned by Acelity for $2.9bn in cash.

Editor’s Remarks: Drugmaker Allergan agreed to another acquisition that sees its total M&A deals climbing to twelve this year alone. LifeCell is a regenerative unit that produces tissue products used in breast reconstruction and hernia surgeries. A spokesperson for the company announced that Allergan is hoping to increase its medical aesthetics portfolio, in an acquisition strategy that has been described as one of the ‘stepping stones’. A number of deals that Allergan has been involved in during the year have been dropped due to changes in the law, and Trump’s presidency in 2017 could see a change in competition laws that prevent this deal from passing.

What to watch: Allergan, LifeCell, Acelity, Trump, M&A

Get articles like this straight to your inbox each morning with our Breakfast Briefing. Sign up by clicking here!

Log in with your details

or    

Forgot your details?

Create Account

Send this to a friend